Application of cervical cancer staging in early-stage cervical cancer: a prospective, randomized controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036641

Enrollment

Unknown

Registered

2020-08-24

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Control group:Laparoscopic radical hysterectomy+bilateral fallopian tube/adnexectomy+pelvic lymph nodes

Intervention group:Laparoscopic hysterectomy+bilateral fallopian tube/adnexectomy+pelvic lymph nodes

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. The clinical diagnosis of early cervical cancer (IA1 contain lymphatic vascular invasion, group, IB1); 2. The preoperative pathological diagnosis of cervical squamous carcinoma, cervical gland scale cancer or cervical adenocarcinoma; 3. Aged <= 45 years; 4. Manual classification: the Karnofsky score 60 or higher; 5. First treatment; 6. The subjects volunteer to join the study, sign the informed consent, and have good compliance, and cooperate with the follow-up.

Exclusion criteria

Exclusion criteria: 1. Various taboos cannot accept surgery; 2. Patients who can accept pneumoperitoneum free surgery.

Design outcomes

Primary

Measure	Time frame
recurrence rate;	—

Secondary

Measure	Time frame
5-year OS;Intraoperative complication;adverse reaction;	—

Countries

China

Contacts

Public ContactKeqin Hua

Obstetrics & Gynecology Hospital of Fudan University

huakeqinjiaoshou@126.com+86 15021803963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026